Beyond Survival: Measuring Treatment Tolerability with Patient-Reported Outcomes in the Lymphoma Immunotherapy Era

Elisa Hofmeister, Ajay Major

Open source

DOI
10.1007/s11899-026-00786-1
Published
2026-08-07
Container
Current Hematologic Malignancy Reports
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11899-026-00786-1,
  title = {Beyond Survival: Measuring Treatment Tolerability with Patient-Reported Outcomes in the Lymphoma Immunotherapy Era},
  author = {Elisa Hofmeister and Ajay Major},
  year = {2026},
  journal = {Current Hematologic Malignancy Reports},
  doi = {10.1007/s11899-026-00786-1},
  url = {https://doi.org/10.1007/s11899-026-00786-1}
}

RIS

TY  - JOUR
TI  - Beyond Survival: Measuring Treatment Tolerability with Patient-Reported Outcomes in the Lymphoma Immunotherapy Era
AU  - Elisa Hofmeister
AU  - Ajay Major
PY  - 2026
JO  - Current Hematologic Malignancy Reports
DO  - 10.1007/s11899-026-00786-1
UR  - https://doi.org/10.1007/s11899-026-00786-1
ER  - 

APA

Hofmeister, E., & Major, A. (2026). Beyond Survival: Measuring Treatment Tolerability with Patient-Reported Outcomes in the Lymphoma Immunotherapy Era. Current Hematologic Malignancy Reports. https://doi.org/10.1007/s11899-026-00786-1

Source records